HIV/AIDS

NEW and NOTEWORTHY

Medical Frailty and Medicaid Work Requirements: Challenges for People with HIV

In 2023, Medicaid covered 46% of people with HIV nationwide with 60% of adults with HIV under 65 in expansion states accessing coverage through the expansion pathway.  This analysis examines Medicaid work requirements and the implementation of medical frailty exclusions for people with HIV in light of CMS’s implementing regulation.

ending the hiv epidemic (ehe) initiative

Ending the HIV Epidemic Funding Tracker

This tracker provides up-to-date data on federal Ending the HIV Epidemic (EHE) funding, including an overview of funding mechanisms by year, agency, grant mechanism, and jurisdiction.

HIV in the U.S.

The U.S. HIV/AIDS Epidemic

This fact sheet provides the latest data on the U.S. HIV epidemic, including key trends over time, impact by region and population, and information on the U.S. government’s response.

HIV Testing in the United States

This fact sheet provides information on key HIV testing statistics, testing recommendations, insurance coverage of HIV testing, testing sites and policies, and types of tests available.

The Ryan White Program

This fact sheet provides an overview of the Ryan White HIV/AIDS Program, the largest HIV-specific federal grant program in the United States.

Greater Than

These accessible, mobile-friendly resources include more than 100 FAQs, in both English and Spanish, covering HIV and STD basics, testing, prevention and treatment. Greater Than can also help you find free and low cost testing near you. 

 

global hiv/aids epidemic

PEPFAR Policy Resource Hub

This hub brings together key U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) policy resources – from KFF, the U.S. government, and others – that can be used to inform policy discussions and research. More items will be added to the hub over time.

The Global HIV/AIDS Epidemic

This updated fact sheet provides the latest data on the global HIV/AIDS epidemic, including impact on affected and vulnerable populations, treatment and prevention efforts, and an overview of the U.S. and global responses to the epidemic.

Global HIV/AIDS Timeline

The Global HIV/AIDS Timeline is an ongoing reference tool for the many political, scientific, cultural, and community developments that have occurred over the history of the HIV/AIDS epidemic.

Stay informed.

Stay informed.

Filter

221 - 230 of 700 Results

  • A Little-Noticed Win in Global HIV Treatment

    News Release

    In his latest column for The Wall Street Journal's Think Tank, Drew Altman discusses a recent success in global HIV treatment and how successes may get less attention than they deserve because of prevailing attitudes about the corruption in foreign aid. All previous columns by Drew Altman are available.

  • Kaiser/UNAIDS Study Finds Slight Increase In Donor Government Funding for AIDS In 2014

    News Release

    Increase Mainly Due to U.K.; However, Funding from Half of Fourteen Donor Governments Declined As world leaders meet to discuss global financing for development, a new report from the Kaiser Family Foundation and the Joint United Nations Programme on HIV/AIDS (UNAIDS) finds that although there was a slight increase in funding to respond to HIV in low- and middle-income countries in 2014, seven of 14 donor governments actually decreased funding, two remained flat and funding…

  • Financing the Response to HIV in Low- and Middle-Income Countries: International Assistance from Donor Governments in 2014

    Report

    This report provides an analysis of donor government funding to address the HIV response in low- and middle-income countries in 2014, the latest year available, as well as trends over time. It includes both bilateral funding from donors and their multilateral contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), UNITAID, and Joint United Nations Programme on HIV/AIDS (UNAIDS).

  • The ACA and People with HIV: Profiles from the Field

    Issue Brief

    This brief provides profiles of twelve individuals living with HIV to offer an in-depth look at how the Affordable Care Act (ACA) has affected their healthcare and coverage. Participants live in California, Florida, Georgia, New York, and Texas and discuss their enrollment and coverage experience, including whether they got new coverage (in the Marketplace or Medicaid), how their HIV care has been affected, and the role of the Ryan White HIV/AIDS Program.

  • The ACA and People with HIV: Profiles from the Field

    News Release

    New in-depth profiles of 12 people with HIV highlight how the Affordable Care Act’s coverage expansions impacted their access to coverage and care. While some experienced serious bumps along the way, those who gained coverage through Medicaid and the Marketplaces were largely able to meet both their HIV and non-HIV care needs. At the same time, the Ryan White HIV/AIDS Program continued to play a role in HIV care and coverage, both for those who remained…

  • The Ryan White Program and Insurance Purchasing in the ACA Era: An Early Look at Five States

    Issue Brief

    This issue brief examines the role that the Ryan White Program has played in helping HIV positive clients purchase insurance coverage from both a historical and an Affordable Care Act (ACA) era perspective. The ACA era analysis focuses on activities in five states during the first open enrollment period and looks specifically at insurance purchasing through the health insurance marketplaces. The states analyzed are California, Florida, Georgia, New York, and Texas.

  • Issue Brief Looks At Experiences of People with HIV With Health Coverage Under the ACA

    News Release

    A new Kaiser Family Foundation issue brief examines the impact of the Affordable Care Act (ACA) on people with HIV in five states – California, Florida, Georgia, New York and Texas. Findings are drawn from focus groups in which participants discussed their experiences during the first year of the ACA’s major coverage expansions, with the goal of understanding the implications for individual HIV health outcomes and the nation's response to the epidemic. While many focus group…